MAY 6, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Zoladex (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling change to Zoladex (goserelin); does not contain clinical trial data and conveys only the regulatory action taken.
Reported
Approval date2026-05-06
Submission classLabeling
Active ingredient and strengthGoserelin 3.6 mg implant